So was the CHF partnership .... It was mentioned in the CC on the 23 November on the morning of the AGM at around 9:08 am .... I posted about it in the below post in real time when SI mentioned it as I was on the call and it confirmed what I have been saying all along - that a CHF partnership will not be finalised until the FDA provide feedback on the approval pathway for Rexlemestrocel-L for CHF
https://hotcopper.com.au/threads/an....7103086/page-2?post_id=64932550#.Y6EeRX1BzIU
Like I have been trying to tell some on here, there are two very different CHF partnership deals being considered .... SI just confirmed that they are working with partners on CHF but are waiting for the FDA guidance on the pathway to approval before these negotiations are finalised - just sayin'
GVHD the first step, page-77
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |